γδ T cells: origin and fate, subsets, diseases and immunotherapy
Y Hu, Q Hu, Y Li, L Lu, Z Xiang, Z Yin… - … and Targeted Therapy, 2023 - nature.com
The intricacy of diseases, shaped by intrinsic processes like immune system exhaustion and
hyperactivation, highlights the potential of immune renormalization as a promising strategy …
hyperactivation, highlights the potential of immune renormalization as a promising strategy …
Cancer immunotherapy with γδ T cells: many paths ahead of us
D Kabelitz, R Serrano, L Kouakanou, C Peters… - Cellular & molecular …, 2020 - nature.com
Abstract γδ T cells play uniquely important roles in stress surveillance and immunity for
infections and carcinogenesis. Human γδ T cells recognize and kill transformed cells …
infections and carcinogenesis. Human γδ T cells recognize and kill transformed cells …
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European …
P Ljungman, R de la Camara, C Robin… - The Lancet infectious …, 2019 - thelancet.com
Cytomegalovirus is one of the most important infections to occur after allogeneic
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …
Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation
Natural killer (NK) cells contribute to the first line of defense against viruses and to the
control of tumor growth and metastasis spread. The discovery of HLA class I specific …
control of tumor growth and metastasis spread. The discovery of HLA class I specific …
[HTML][HTML] NK cells and ILCs in tumor immunotherapy
Cells of the innate immunity play an important role in tumor immunotherapy. Thus, NK cells
can control tumor growth and metastatic spread. Thanks to their strong cytolytic activity …
can control tumor growth and metastatic spread. Thanks to their strong cytolytic activity …
[HTML][HTML] History of hematopoietic cell transplantation: challenges and progress
N Granot, R Storb - Haematologica, 2020 - ncbi.nlm.nih.gov
After more than 60 years of research in allogeneic hematopoietic cell transplantation (HCT),
this therapy has advanced from one that was declared dead in the 1960s to a standard …
this therapy has advanced from one that was declared dead in the 1960s to a standard …
Hematopoietic stem cell transplantation in its 60s: a platform for cellular therapies
Over the last 60 years, more than a million patients received hematopoietic cell
transplantation. Having incorporated multiple changes in clinical practices, it remains a …
transplantation. Having incorporated multiple changes in clinical practices, it remains a …
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function
Hemophagocytic lymphohistiocytosis (HLH) is characterized by immune dysregulation due
to inadequate restraint of overactivated immune cells and is associated with a variable …
to inadequate restraint of overactivated immune cells and is associated with a variable …
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell …
The number of HLA-haploidentical hematopoietic cell transplants continues to increase
worldwide due to recent improvements in outcomes, allowing more patients with …
worldwide due to recent improvements in outcomes, allowing more patients with …
Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions
N Martinez-Cibrian, R Zeiser, JA Perez-Simon - Blood reviews, 2021 - Elsevier
Graft-versus-host disease (GvHD) was first described in 1959, since then major efforts have
been made in order to understand its physiopathology and animal models have played a …
been made in order to understand its physiopathology and animal models have played a …